PROCEPT BioRobotics Corporation: Investors Have Opportunity to Lead Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, has urged purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock who incurred losses exceeding $100,000 to consider their options in leading a class action lawsuit.

The lawsuit targets shares purchased between February 28, 2024, and February 25, 2026. Plaintiffs allege that the company made materially false and misleading statements regarding its business and future prospects.

Rosen Law Firm has stated that an important deadline for investors to seek to lead the lawsuit is September 22. Those interested in discussing their rights or the opportunity to serve as lead plaintiff are encouraged to contact the firm.

Representatives for PROCEPT BioRobotics Corporation could not be reached for comment. The company is known for developing advanced robotics for the healthcare industry.